Is PPARG the key gene in diabetic retinopathy?
- 6 December 2011
- journal article
- editorial
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (1), 1-3
- https://doi.org/10.1111/j.1476-5381.2011.01443.x
Abstract
Diabetic retinopathy, a microvascular complication of diabetes mellitus, is major cause of non-inherited blindness among adults. Although diabetic retinopathy is a common complication of diabetes, we still know little about the underlying molecular mechanisms. In recent years, complex connections between important molecules and pathways in the onset and progression of diabetic retinopathy, such as advanced glycation end products, oxidative stress and inflammation, have been elucidated. Biochemical, genetic and functional studies strongly indicate peroxisome proliferator-activated receptor-γ (PPARγ), a pleiotropic transcription factor, as a primary target in the treatment of diabetic retinopathy. In this issue, Song et al. detail the role of PPARγ in diabetic retinopathy-related disorders, illustrating PPARγ-mediated inhibition of diabetes-induced leukostasis and leakage, and its beneficial role in modulating inflammation, angiogenesis and apoptosis in retinal and endothelial cells. Moreover, they describe alternative treatments for diabetic retinopathy, such as plant-derived PPARγ ligands, proposing their use - in combination with standard therapies - for modulation of diabetic retinopathy.Keywords
This publication has 14 references indexed in Scilit:
- PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved IssuesPPAR Research, 2010
- Effect of systemic medications on onset and progression of diabetic retinopathyNature Reviews Endocrinology, 2010
- Characterization of a Novel Polymorphism in PPARG Regulatory Region Associated with Type 2 Diabetes and Diabetic Retinopathy in ItalyJournal of Biomedicine and Biotechnology, 2008
- Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory responseBMC Medical Genomics, 2008
- Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γTrends in Cardiovascular Medicine, 2008
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- Controlling nuclear receptors: the circular logic of cofactor cyclesNature Reviews Molecular Cell Biology, 2005
- A Novel Peroxisome Proliferator-activated Receptor γ Isoform with Dominant Negative Activity Generated by Alternative SplicingPublished by Elsevier BV ,2005
- The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-β and TNF-α in human breast cancer cellsCarcinogenesis: Integrative Cancer Research, 2005
- Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and PharmacologyEndocrine Reviews, 2004